Integration of mathematical model predictions into routine workflows to support clinical decision making in haematology.

Clinical decision-making Computer simulation Data management Haematology Individual therapy planning Mathematical modelling Model-based treatment optimization Routine workflow Support system

Journal

BMC medical informatics and decision making
ISSN: 1472-6947
Titre abrégé: BMC Med Inform Decis Mak
Pays: England
ID NLM: 101088682

Informations de publication

Date de publication:
10 02 2020
Historique:
received: 08 11 2018
accepted: 29 01 2020
entrez: 12 2 2020
pubmed: 12 2 2020
medline: 10 10 2020
Statut: epublish

Résumé

Individualization and patient-specific optimization of treatment is a major goal of modern health care. One way to achieve this goal is the application of high-resolution diagnostics together with the application of targeted therapies. However, the rising number of different treatment modalities also induces new challenges: Whereas randomized clinical trials focus on proving average treatment effects in specific groups of patients, direct conclusions at the individual patient level are problematic. Thus, the identification of the best patient-specific treatment options remains an open question. Systems medicine, specifically mechanistic mathematical models, can substantially support individual treatment optimization. In addition to providing a better general understanding of disease mechanisms and treatment effects, these models allow for an identification of patient-specific parameterizations and, therefore, provide individualized predictions for the effect of different treatment modalities. In the following we describe a software framework that facilitates the integration of mathematical models and computer simulations into routine clinical processes to support decision-making. This is achieved by combining standard data management and data exploration tools, with the generation and visualization of mathematical model predictions for treatment options at an individual patient level. By integrating model results in an audit trail compatible manner into established clinical workflows, our framework has the potential to foster the use of systems-medical approaches in clinical practice. We illustrate the framework application by two use cases from the field of haematological oncology.

Sections du résumé

BACKGROUND
Individualization and patient-specific optimization of treatment is a major goal of modern health care. One way to achieve this goal is the application of high-resolution diagnostics together with the application of targeted therapies. However, the rising number of different treatment modalities also induces new challenges: Whereas randomized clinical trials focus on proving average treatment effects in specific groups of patients, direct conclusions at the individual patient level are problematic. Thus, the identification of the best patient-specific treatment options remains an open question. Systems medicine, specifically mechanistic mathematical models, can substantially support individual treatment optimization. In addition to providing a better general understanding of disease mechanisms and treatment effects, these models allow for an identification of patient-specific parameterizations and, therefore, provide individualized predictions for the effect of different treatment modalities.
RESULTS
In the following we describe a software framework that facilitates the integration of mathematical models and computer simulations into routine clinical processes to support decision-making. This is achieved by combining standard data management and data exploration tools, with the generation and visualization of mathematical model predictions for treatment options at an individual patient level.
CONCLUSIONS
By integrating model results in an audit trail compatible manner into established clinical workflows, our framework has the potential to foster the use of systems-medical approaches in clinical practice. We illustrate the framework application by two use cases from the field of haematological oncology.

Identifiants

pubmed: 32041606
doi: 10.1186/s12911-020-1039-x
pii: 10.1186/s12911-020-1039-x
pmc: PMC7011438
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't Video-Audio Media

Langues

eng

Sous-ensembles de citation

IM

Pagination

28

Références

J Cancer Res Clin Oncol. 2018 Feb;144(2):343-358
pubmed: 29103159
PLoS Comput Biol. 2019 Mar 6;15(3):e1006775
pubmed: 30840616
Lancet. 2007 Jul 28;370(9584):342-50
pubmed: 17662883
Blood. 2004 Aug 1;104(3):634-41
pubmed: 15016643
Blood. 2014 Jul 24;124(4):511-8
pubmed: 24859364
BMC Med Inform Decis Mak. 2016 Jul 21;16 Suppl 2:87
pubmed: 27460182
Haematologica. 2018 Nov;103(11):1825-1834
pubmed: 29954936
BMC Med Inform Decis Mak. 2015 Nov 30;15:100
pubmed: 26621059
Nat Med. 2006 Oct;12(10):1181-4
pubmed: 17013383
BMC Med Inform Decis Mak. 2011 Mar 08;11:16
pubmed: 21385459
PLoS One. 2013 Jun 06;8(6):e65630
pubmed: 23755260
Nat Genet. 2017 Mar;49(3):332-340
pubmed: 28092685
Sci Rep. 2018 Aug 17;8(1):12330
pubmed: 30120281
BMC Med Inform Decis Mak. 2015 Feb 07;15:7
pubmed: 25889768
PLoS Comput Biol. 2017 Dec 15;13(12):e1005898
pubmed: 29244826
Blood. 2013 Jan 10;121(2):378-84
pubmed: 23175686
Leuk Lymphoma. 2016 Jul;57(7):1697-708
pubmed: 26666299
BMC Med Inform Decis Mak. 2008 Jan 28;8:6
pubmed: 18226244
Theor Biol Med Model. 2014 May 26;11:24
pubmed: 24886056
Ann Oncol. 2003 Jun;14(6):881-93
pubmed: 12796026
BMC Med Inform Decis Mak. 2007 Aug 13;7:23
pubmed: 17697328
J Theor Biol. 2010 May 21;264(2):287-300
pubmed: 20083124
BMC Syst Biol. 2014 Dec 24;8:138
pubmed: 25539928

Auteurs

Katja Hoffmann (K)

Institute for Medical Informatics and Biometry, Faculty of Medicine Carl Gustav Carus, Technische Universität Dresden, Dresden, Germany.

Katja Cazemier (K)

Institute for Medical Informatics and Biometry, Faculty of Medicine Carl Gustav Carus, Technische Universität Dresden, Dresden, Germany.

Christoph Baldow (C)

Institute for Medical Informatics and Biometry, Faculty of Medicine Carl Gustav Carus, Technische Universität Dresden, Dresden, Germany.

Silvio Schuster (S)

Institute for Medical Informatics and Biometry, Faculty of Medicine Carl Gustav Carus, Technische Universität Dresden, Dresden, Germany.

Yuri Kheifetz (Y)

Institute for Medical Informatics, Statistics and Epidemiology, Faculty of Medicine, University of Leipzig, Leipzig, Germany.

Sibylle Schirm (S)

Institute for Medical Informatics, Statistics and Epidemiology, Faculty of Medicine, University of Leipzig, Leipzig, Germany.

Matthias Horn (M)

Institute for Medical Informatics, Statistics and Epidemiology, Faculty of Medicine, University of Leipzig, Leipzig, Germany.

Thomas Ernst (T)

Abteilung Hämatologie/Onkologie, Klinik für Innere Medizin II, Universitätsklinikum Jena, Jena, Germany.

Constanze Volgmann (C)

Abteilung Hämatologie/Onkologie, Klinik für Innere Medizin II, Universitätsklinikum Jena, Jena, Germany.

Christian Thiede (C)

Department of Internal Medicine, Medical Clinic I, University Hospital Carl Gustav Carus Dresden, Dresden, Germany.

Andreas Hochhaus (A)

Abteilung Hämatologie/Onkologie, Klinik für Innere Medizin II, Universitätsklinikum Jena, Jena, Germany.

Martin Bornhäuser (M)

Department of Internal Medicine, Medical Clinic I, University Hospital Carl Gustav Carus Dresden, Dresden, Germany.
National Center for Tumor Diseases (NCT), Partner Site Dresden, Dresden, Germany.

Meinolf Suttorp (M)

Pediatric Hematology and Oncology, Department of Pediatrics, University Hospital Carl Gustav Carus Dresden, Dresden, Germany.

Markus Scholz (M)

Institute for Medical Informatics, Statistics and Epidemiology, Faculty of Medicine, University of Leipzig, Leipzig, Germany.

Ingmar Glauche (I)

Institute for Medical Informatics and Biometry, Faculty of Medicine Carl Gustav Carus, Technische Universität Dresden, Dresden, Germany.

Markus Loeffler (M)

Institute for Medical Informatics, Statistics and Epidemiology, Faculty of Medicine, University of Leipzig, Leipzig, Germany.

Ingo Roeder (I)

Institute for Medical Informatics and Biometry, Faculty of Medicine Carl Gustav Carus, Technische Universität Dresden, Dresden, Germany. ingo.roeder@tu-dresden.de.
National Center for Tumor Diseases (NCT), Partner Site Dresden, Dresden, Germany. ingo.roeder@tu-dresden.de.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH